SCHEMBL19628264

SCHEMBL19628264

CN(CC/N=C/c1cc2ccccc2c(-c2c(O)c(/C=N/CCN(C)Cc3cc(C(C)(C)C)cc(C(C)(C)C)c3O)cc3ccccc23)c1O)Cc1cc(C(C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 7/20 0.52
CYP2C19 P33261 4/20 0.39
CYP2D6 P10635 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2C9 P11712 3/20 0.39
ALOX5 P09917 4/20 0.38
PTGS2 P35354 4/20 0.38
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
ADRA2A P08913 1/20 0.34
ACHE P22303 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
KCNH2 Q12809 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
GAA P10253 2/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628267 0.94 HIF1A (0.51) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL19628265 0.88 HIF1A (0.42) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL25039850 0.86 HIF1A (0.49) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL8352502 0.81 HIF1A (0.53) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL16963068 0.73 ALOX5 (0.45) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL17656826 0.73 ALOX5 (0.45) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL14883383 0.73 ALOX5 (0.45) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL6053413 0.73 HIF1A (0.59) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL14804453 0.71 ALOX5 (0.43) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9
SCHEMBL20810350 0.71 HIF1A (0.47) HIF1ACYP2C19CYP2D6CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170335061-A1 ISOTACTIC POLYETHERS AND BIMETALLIC CATALYSTS, METHODS OF MAKING SAME, AND USES THEREOF NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170335061-A1 ISOTACTIC POLYETHERS AND BIMETALLIC CATALYSTS, METHODS OF MAKING SAME, AND USES THEREOF SQLE, PAOX, AGL HIF1A 4222/4885CYP2C19 2162/4885CYP2D6 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.